Oppenheimer & Co’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,500
| Closed | -$206K | – | 1436 |
|
|
2024
Q1 | $206K | Sell |
3,500
-8,730
| -71% | -$513K | ﹤0.01% | 1334 |
|
|
2023
Q4 | $732K | Buy |
12,230
+391
| +3% | +$23.4K | 0.01% | 837 |
|
|
2023
Q3 | $450K | Buy |
11,839
+2,951
| +33% | +$112K | 0.01% | 986 |
|
|
2023
Q2 | $810K | Buy |
8,888
+1,548
| +21% | +$141K | 0.02% | 784 |
|
|
2023
Q1 | $484K | Sell |
7,340
-175
| -2% | -$11.5K | 0.01% | 955 |
|
|
2022
Q4 | $389K | Buy |
7,515
+132
| +2% | +$6.83K | 0.01% | 994 |
|
|
2022
Q3 | $504K | Sell |
7,383
-31
| -0.4% | -$2.12K | 0.01% | 897 |
|
|
2022
Q2 | $335K | Buy |
7,414
+55
| +0.7% | +$2.49K | 0.01% | 1065 |
|
|
2022
Q1 | $374K | Buy |
+7,359
| New | +$374K | 0.01% | 1106 |
|
|
2021
Q1 | – | Sell |
-4,267
| Closed | -$244K | – | 1434 |
|
|
2020
Q4 | $244K | Sell |
4,267
-3,182
| -43% | -$182K | 0.01% | 1166 |
|
|
2020
Q3 | $225K | Buy |
+7,449
| New | +$225K | 0.01% | 1109 |
|